United-Guardian Inc

United-Guardian Inc (UG) Stock Analysis

$6.780

-0.020 (-0.29%)At close

Loading chart…
High
6.885
Open
6.690
VWAP
6.77
Volume
16.51K
Mkt Cap
42.64M
Low
6.650
Amount
111.82K
EV/EBITDA, TTM
0.00

United-Guardian, Inc. is a manufacturer of cosmetic ingredients, sexual wellness ingredients, pharmaceuticals, and medical lubricants. The Company’s product lines include the Lubrajel line of multifunctional hydrogel formulations, which are designed to provide sensory enhancement, lubrication, hydration, and texture to both personal care and medical products. Its four distinct product categories include cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. Its COSMOS line of products includes Lubrajel Natural, Lubrajel Marine, Lubrajel Oil Natural, and Lubrajel Terra. Its medical lubricants include a line of hydrogel formulations designed to offer sensory enhancement and lubrication to medical products. The Company’s pharmaceutical products include an FDA-approved prescription drug that is used primarily to prevent and to dissolve calcifications in urethral catheters, as well as a chlorine-based topical antimicrobial.

u-g.com

AI analysis of United-Guardian Inc (UG)

Buy

United-Guardian Inc appears to be a good buy right now due to its strong recent performance and favorable financial metrics. The current price is $7.25, which is 58.3% of its 52-week range, indicating it is closer to the low end than the high. The company has shown a 5-day change of +9.10% and a year-to-date change of +18.27%, reflecting positive momentum. Additionally, the gross margin stands at 49.73%, which is healthy, and the forward P/E ratio is 26.53, suggesting growth potential. However, the RSI is at 78.45, indicating that the stock may be overbought, which is a risk to consider.

Valuation Metrics

The current forward P/E ratio for United-Guardian Inc (UG) is 26.53, compared to its 5-year average forward P/E of 4.61.

Forward P/E

Strongly Overvalued
5Y Average P/E
4.61
Current P/E
26.53
Overvalued
14.78
Undervalued
-5.56

Forward EV/EBITDA

Strongly Undervalued
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued
0.00
Undervalued
0.00

Forward P/S

Strongly Undervalued
5Y Average P/S
0.00
Current P/S
0.00
Overvalued
0.00
Undervalued
0.00

Alphio AI Price Scenarios for UG

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%UG

$13.06

Scenario price

B

Base

Base · 50%UG

$11.05

Scenario price

B

Bear

Bear · 25%UG

$10.96

Scenario price

Events Timeline

2025-11-06 (ET)

09:04:50

United-Guardian Announces Q3 Earnings Per Share of 6 Cents Compared to 19 Cents Last Year

2025-08-08 (ET)

09:05:14

United-Guardian reports Q2 EPS 14c vs 21c

2025-05-21 (ET)

09:05:44

United-Guardian appoints Donna Vigilante to board of directors

2025-05-08 (ET)

09:03:12

United-Guardian reports Q1 EPS 12c vs 20c last year

2025-03-21 (ET)

09:04:32

United-Guardian reports FY24 EPS 71c vs 56c last year

News

UG FAQ — answered by Alphio AI

United-Guardian, Inc. is a manufacturer of cosmetic ingredients, sexual wellness ingredients, pharmaceuticals, and medical lubricants. The Company’s product lines include the Lubrajel line of multifunctional hydrogel formulations, which are designed to provide sensory enhancement, lubrication, hydration, and texture to both personal care and medical products. Its four distinct product categories include cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. Its COSMOS line of products includes Lubrajel Natural, Lubrajel Marine, Lubrajel Oil Natural, and Lubrajel Terra. Its medical lubricants include a line of hydrogel formulations designed to offer sensory enhancement and lubrication to medical products. The Company’s pharmaceutical products include an FDA-approved prescription drug that is used primarily to prevent and to dissolve calcifications in urethral catheters, as well as a chlorine-based topical antimicrobial. It operates in the Healthcare sector (PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS industry).

United-Guardian Inc appears to be a good buy right now due to its strong recent performance and favorable financial metrics. The current price is $7.25, which is 58.3% of its 52-week range, indicating it is closer to the low end than the high. The company has shown a 5-day change of +9.10% and a year-to-date change of +18.27%, reflecting positive momentum. Additionally, the gross margin stands at 49.73%, which is healthy, and the forward P/E ratio is 26.53, suggesting growth potential. However, the RSI is at 78.45, indicating that the stock may be overbought, which is a risk to consider.

Community

More ↗

No posts yet

Sign up or log in to join the discussion

Related articles

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Start trading